Phase 1 clinical trial of B-Cell Maturation Antigen (BCMA) NEX-T® Chimeric Antigen Receptor (CAR) T cell therapy CC-98633/BMS-986354 in participants with triple-class exposed multiple myeloma
B细胞成熟抗原（BCMA）NEX-T®嵌合抗原受体（CAR）T细胞疗法CC-98633/BMS-986354在接受过三线抗肿瘤治疗的多发性骨髓瘤患者中的I期临床试验
期刊:Leukemia
影响因子:13.4
doi:10.1038/s41375-025-02518-5
Ravi, Gayathri; Richard, Shambavi; Kumar, Shaji; Atrash, Shebli; Liedtke, Michaela; Kaur, Gurbakhash; Derman, Benjamin; Bergsagel, P Leif; Mailankody, Sham; McCarthy, Philip; Shrestha, Alok; Kelly, Lisa M; Ly, Thomas; Das, Sharmila; Thorpe, Jerill; Maier, Alison; Varun, Divya; Navarro, Garnet; Burgess, Michael R; Hege, Kristen; Koegel, Ashley K; Costa, Luciano J
B细胞
肿瘤
T细胞
肿瘤免疫
多发性骨髓瘤
信号转导
多发性硬化症
T细胞
骨髓瘤
细胞生物学
免疫/内分泌
